TransMedics Group Inc.

NASDAQ: TMDX · Real-Time Price · USD
122.05
0.47 (0.39%)
At close: May 19, 2025, 3:59 PM
121.72
-0.27%
After-hours: May 19, 2025, 07:59 PM EDT

TransMedics Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Product Revenue 273.87M 176.05M 79.23M
Product Revenue Growth +55.56% +122.19% n/a
Service Revenue Revenue 167.67M 65.55M 14.22M
Service Revenue Revenue Growth +155.78% +360.84% n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 28, 2019 Sep 28, 2019 Jun 29, 2019 Mar 30, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 30, 2017 Sep 30, 2017 Jul 1, 2017 Apr 1, 2017
Selling, General, and Administrative Revenue 43.63M 46.91M 42.66M 42.8M 36.06M 34.56M 30.65M 29.36M 24.98M 21.73M 16.85M 17.38M 13.94M 12M 10.34M 9.16M 6.79M 6.18M 5.49M 5.87M 6.65M 6.17M 6.52M 6.25M 4.65M 4.37M 2.8M 2.9M 2.24M 1.63M 1.81M 2.33M 2.08M
Selling, General, and Administrative Revenue Growth -6.99% +9.96% -0.32% +18.67% +4.34% +12.75% +4.42% +17.50% +15.00% +28.93% -3.05% +24.69% +16.16% +16.11% +12.80% +35.01% +9.88% +12.43% -6.37% -11.80% +7.76% -5.31% +4.29% +34.34% +6.38% +56.27% -3.55% +29.55% +37.17% -9.88% -22.23% +11.99% n/a
Research and Development Revenue 17.16M 16.46M 14.27M 13.86M 11.38M 10.76M 38.34M 8.29M 5.87M 5.76M 6.81M 6.71M 7.53M 6.31M 5.16M 6.29M 4.53M 4.55M 4.16M 3.9M 6.22M 6.26M 4.94M 4.79M 3.88M 3.49M 3.27M 3.43M 3.46M 3.4M 3.4M 4.19M 4.08M
Research and Development Revenue Growth +4.23% +15.41% +2.94% +21.78% +5.75% -71.94% +362.48% +41.22% +2.00% -15.45% +1.40% -10.88% +19.32% +22.29% -17.98% +38.90% -0.35% +9.46% +6.46% -37.30% -0.59% +26.79% +3.18% +23.31% +11.36% +6.54% -4.69% -0.92% +1.85% 0.00% -18.86% +2.86% n/a